Literature DB >> 21381732

Rational design of β-sheet ligands against Aβ42-induced toxicity.

Katrin Hochdörffer1, Julia März-Berberich, Luitgard Nagel-Steger, Matthias Epple, Wolfgang Meyer-Zaika, Anselm H C Horn, Heinrich Sticht, Sharmistha Sinha, Gal Bitan, Thomas Schrader.   

Abstract

A β-sheet-binding scaffold was equipped with long-range chemical groups for tertiary contacts toward specific regions of the Alzheimer's Aβ fibril. The new constructs contain a trimeric aminopyrazole carboxylic acid, elongated with a C-terminal binding site, whose influence on the aggregation behavior of the Aβ(42) peptide was studied. MD simulations after trimer docking to the anchor point (F19/F20) suggest distinct groups of complex structures each of which featured additional specific interactions with characteristic Aβ regions. Members of each group also displayed a characteristic pattern in their antiaggregational behavior toward Aβ. Specifically, remote lipophilic moieties such as a dodecyl, cyclohexyl, or LPFFD fragment can form dispersive interactions with the nonpolar cluster of amino acids between I31 and V36. They were shown to strongly reduce Thioflavine T (ThT) fluorescence and protect cells from Aβ lesions (MTT viability assays). Surprisingly, very thick fibrils and a high β-sheet content were detected in transmission electron microscopy (TEM) and CD spectroscopic experiments. On the other hand, distant single or multiple lysines which interact with the ladder of stacked E22 residues found in Aβ fibrils completely dissolve existing β-sheets (ThT, CD) and lead to unstructured, nontoxic material (TEM, MTT). Finally, the triethyleneglycol spacer between heterocyclic β-sheet ligand and appendix was found to play an active role in destabilizing the turn of the U-shaped protofilament. Fluorescence correlation spectroscopy (FCS) and sedimentation velocity analysis (SVA) provided experimental evidence for some smaller benign aggregates of very thin, delicate structure (TEM, MTT). A detailed investigation by dynamic light scattering (DLS) and other methods proved that none of the new ligands acts as a colloid. The evolving picture for the disaggregation mechanism by these new hybrid ligands implies transformation of well-ordered fibrils into less structured aggregates with a high molecular weight. In the few cases where fibrillar components remain, these display a significantly altered morphology and have lost their acute cellular toxicity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21381732     DOI: 10.1021/ja107675n

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  9 in total

Review 1.  Flexibility and binding affinity in protein-ligand, protein-protein and multi-component protein interactions: limitations of current computational approaches.

Authors:  Pierre Tuffery; Philippe Derreumaux
Journal:  J R Soc Interface       Date:  2011-10-12       Impact factor: 4.118

2.  Protective spin-labeled fluorenes maintain amyloid beta peptide in small oligomers and limit transitions in secondary structure.

Authors:  Robin Altman; Sonny Ly; Silvia Hilt; Jitka Petrlova; Izumi Maezawa; Tamás Kálai; Kálmán Hideg; Lee-Way Jin; Ted A Laurence; John C Voss
Journal:  Biochim Biophys Acta       Date:  2015-09-14

3.  C-terminal tetrapeptides inhibit Aβ42-induced neurotoxicity primarily through specific interaction at the N-terminus of Aβ42.

Authors:  Huiyuan Li; Zhenming Du; Dahabada H J Lopes; Erica A Fradinger; Chunyu Wang; Gal Bitan
Journal:  J Med Chem       Date:  2011-11-28       Impact factor: 7.446

Review 4.  The role of molecular simulations in the development of inhibitors of amyloid β-peptide aggregation for the treatment of Alzheimer's disease.

Authors:  Justin A Lemkul; David R Bevan
Journal:  ACS Chem Neurosci       Date:  2012-08-27       Impact factor: 4.418

5.  Designed α-sheet peptides inhibit amyloid formation by targeting toxic oligomers.

Authors:  Gene Hopping; Jackson Kellock; Ravi Pratap Barnwal; Peter Law; James Bryers; Gabriele Varani; Byron Caughey; Valerie Daggett
Journal:  Elife       Date:  2014-07-15       Impact factor: 8.140

6.  Rationally designed peptidomimetic modulators of aβ toxicity in Alzheimer's disease.

Authors:  K Rajasekhar; S N Suresh; Ravi Manjithaya; T Govindaraju
Journal:  Sci Rep       Date:  2015-01-30       Impact factor: 4.379

7.  Brazilin inhibits amyloid β-protein fibrillogenesis, remodels amyloid fibrils and reduces amyloid cytotoxicity.

Authors:  Wen-Jie Du; Jing-Jing Guo; Ming-Tao Gao; Sheng-Quan Hu; Xiao-Yan Dong; Yi-Fan Han; Fu-Feng Liu; Shaoyi Jiang; Yan Sun
Journal:  Sci Rep       Date:  2015-01-23       Impact factor: 4.379

8.  β-Hairpin mimics containing a piperidine-pyrrolidine scaffold modulate the β-amyloid aggregation process preserving the monomer species.

Authors:  S Pellegrino; N Tonali; E Erba; J Kaffy; M Taverna; A Contini; M Taylor; D Allsop; M L Gelmi; S Ongeri
Journal:  Chem Sci       Date:  2016-10-07       Impact factor: 9.825

Review 9.  Pyrazole Scaffold Synthesis, Functionalization, and Applications in Alzheimer's Disease and Parkinson's Disease Treatment (2011-2020).

Authors:  Xuefei Li; Yanbo Yu; Zhude Tu
Journal:  Molecules       Date:  2021-02-24       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.